Halia Desnuda Galería de Fotos y Vídeos

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

Halia Therapeutics Awarded Novo Nordisk Golden Ticket to Advance Obesity and Inflammation Research

Halia Therapeutics Announces Positive Topline Data and Advances to Second Stage of Phase 2 Clinical Trial for HT-6184 in Patients with Low-Risk Myelodysplastic Syndromes (LR-MDS)

Halia Therapeutics to Participate in Jefferies 2026 Global Healthcare Conference

Halia Therapeutics Strengthens Global Genomics Leadership with Appointment of Paul Jones as Chief Strategy Officer & GM, International Markets

Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit

Halia at Botanic Gardens gets Halal certification

Enrolment concludes in Halia’s Phase IIa trial of HT-6184 for MDS

Halia Therapeutics Appoints Gary Sabin as Executive Chairman and Adds Three Independent Directors to Board

Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer

Halia Therapeutics opens Lehi lab, hopes to test new dementia drug within a year

Halia Therapeutics to Present an Update on Phase II Clinical Trial Data of HT-6184 at the 6th Inflammasome Therapeutics Summit

Kaimana Close Up; Halia Parish

Singapore Botanic Gardens restaurant The Halia to close after 25 years

Halia Therapeutics Wins Novo Nordisk Golden Ticket

AFT Halia, A Custom Fighter Built by Models

HALIA AFT Customs

Goose Island Halia